Chromosome 21 and Down syndrome: from genomics to pathophysiology (original) (raw)
Hsu, L. Y. in Genetic Disorders and the Fetus (ed. Milunsky, A.) 179–248 (Johns Hopkins Univ. Press, Baltimore, 1998). Google Scholar
Bailey, J. A. et al. Recent segmental duplications in the human genome. Science297, 1003–1007 (2002). ArticleCASPubMed Google Scholar
Pentao, L., Wise, C. A., Chinault, A. C., Patel, P. I. & Lupski, J. R. Charcot–Marie–Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nature Genet.2, 292–300 (1992). CASPubMed Google Scholar
de Mollerat, X. J. et al. A genomic rearrangement resulting in a tandem duplication is associated with split hand-split foot malformation 3 (SHFM3) at 10q24. Hum. Mol. Genet.12, 1959–1971 (2003). CASPubMed Google Scholar
Snijders, A. M. et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nature Genet.29, 263–264 (2001). CASPubMed Google Scholar
Ellis, D. & Malcolm, S. Proteolipid protein gene dosage effect in Pelizaeus–Merzbacher disease. Nature Genet.6, 333–4 (1994). CASPubMed Google Scholar
Inoue, K. & Lupski, J. R. Molecular mechanisms for genomic disorders. Annu. Rev. Genomics Hum. Genet.3, 199–242 (2002). CASPubMed Google Scholar
Readhead, C., Schneider, A., Griffiths, I. & Nave, K. A. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron12, 583–595 (1994). CASPubMed Google Scholar
Magyar, J. P. et al. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci.16, 5351–5360 (1996). CASPubMedPubMed Central Google Scholar
Lettice, L. A. et al. A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum. Mol. Genet.12, 1725–1735 (2003). CASPubMed Google Scholar
Albertson, D. G., Collins, C., McCormick, F. & Gray, J. W. Chromosome aberrations in solid tumors. Nature Genet.34, 369–376 (2003). CASPubMed Google Scholar
Hassold, T. & Hunt, P. To err (meiotically) is human: the genesis of human aneuploidy. Nature Rev. Genet.2, 280–291 (2001). CASPubMed Google Scholar
Antonarakis, S. E. 10 years of genomics, chromosome 21, and Down syndrome. Genomics51, 1–16 (1998). CASPubMed Google Scholar
Bandyopadhyay, R. et al. Parental origin and timing of de novo Robertsonian translocation formation. Am. J. Hum. Genet.71, 1456–1462 (2002). CASPubMedPubMed Central Google Scholar
Epstein, C. J. in The Metabolic and Molecular Bases of Inherited Diseases (eds Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle, D.) 1223–1256 (McGraw-Hill, New York, 2001). Google Scholar
Roizen, N. J. & Patterson, D. Down's syndrome. Lancet361, 1281–1289 (2003). PubMed Google Scholar
Pennington, B. F., Moon, J., Edgin, J., Stedron, J. & Nadel, L. The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. Child Dev.74, 75–93 (2003). PubMed Google Scholar
Hattori, M. et al. The DNA sequence of human chromosome 21. Nature405, 311–319 (2000). Landmark study that reports the high-quality nearly-complete nucleotide sequence of HSA21. Important for molecular studies on HSA21. CASPubMed Google Scholar
Lander, E. S. et al. Initial sequencing and analysis of the human genome. Nature409, 860–921 (2001). CASPubMed Google Scholar
Venter, J. C. et al. The sequence of the human genome. Science291, 1304–1351 (2001). CASPubMed Google Scholar
Reymond, A. et al. From PREDs and open reading frames to cDNA isolation: revisiting the human chromosome 21 transcription map. Genomics78, 46–54 (2001). CASPubMed Google Scholar
Reymond, A. et al. Nineteen additional unpredicted transcripts from human chromosome 21. Genomics79, 824–832 (2002). CASPubMed Google Scholar
Davisson, M. et al. Evolutionary breakpoints on human chromosome 21. 78, 99–106 (2001).
Gardiner, K. & Davisson, M. The sequence of human chromosome 21 and implications for research into Down syndrome. Genome Biol.1, 1–9 (2000). Google Scholar
Gardiner, K., Fortna, A., Bechtel, L. & Davisson, M. T. Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene318, 137–147 (2003). CASPubMed Google Scholar
Pletcher, M. T., Wiltshire, T., Cabin, D. E., Villanueva, M. & Reeves, R. H. Use of comparative physical and sequence mapping to annotate mouse chromosome 16 and human chromosome 21. Genomics74, 45–54 (2001). CASPubMed Google Scholar
Rogers, M. A. et al. Hair keratin associated proteins: characterization of a second high sulfur KAP gene domain on human chromosome 21. J. Invest. Dermatol.122, 147–158 (2004). CASPubMed Google Scholar
Shibuya, K. et al. A cluster of 21 keratin-associated protein genes within introns of another gene on human chromosome 21q22. 3. Genomics83, 679–693 (2004). CASPubMed Google Scholar
Mural, R. J. et al. A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science296, 1661–1671 (2002). CASPubMed Google Scholar
Watanabe, H. et al. DNA sequence and comparative analysis of chimpanzee chromosome 22. Nature429, 382–388 (2004). CASPubMed Google Scholar
Kapranov, P. et al. Large-scale transcriptional activity in chromosomes 21 and 22. Science296, 916–919 (2002). DNA chip technology used to study the transcriptional potential of the genome. CASPubMed Google Scholar
Kampa, D. et al. Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. Genome Res.14, 331–342 (2004). CASPubMedPubMed Central Google Scholar
Cawley, S. et al. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell116, 499–509 (2004). DNA chip technology used to identify functional elements of the genome. CASPubMed Google Scholar
Waterston, R. H. et al. Initial sequencing and comparative analysis of the mouse genome. Nature420, 520–562 (2002). The sequence of the mouse genome provided the opportunity for comparative analysis to identify human functional genomic elements. CASPubMed Google Scholar
Dermitzakis, E. T. et al. Numerous potentially functional but non-genic conserved sequences on human chromosome 21. Nature420, 578–582 (2002). CASPubMed Google Scholar
Dermitzakis, E. T. et al. Comparison of human chromosome 21 conserved nongenic sequences (CNGs) with the mouse and dog genomes shows that their selective constraint is independent of their genic environment. Genome Res.14, 852–859 (2004). CASPubMedPubMed Central Google Scholar
Dermitzakis, E. T. et al. Evolutionary discrimination of mammalian conserved non-genic sequences (CNGs). Science302, 1033–1035 (2003). CASPubMed Google Scholar
Kirkness, E. F. et al. The dog genome: survey sequencing and comparative analysis. Science301, 1898–1903 (2003). PubMed Google Scholar
Frazer, K. A. et al. Noncoding sequences conserved in a limited number of mammals in the SIM2 interval are frequently functional. Genome Res.14, 367–372 (2004). CASPubMedPubMed Central Google Scholar
Thomas, J. W. et al. Comparative analyses of multi-species sequences from targeted genomic regions. Nature424, 788–793 (2003). CASPubMed Google Scholar
Patil, N. et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science294, 1719–1723 (2001). A whole chromosome linkage disequilibrium mapping that provides tools for association studies of human complex phenotypes. CASPubMed Google Scholar
Davisson, M. T. et al. Segmental trisomy as a mouse model for Down syndrome. Prog. Clin. Biol. Res.384, 117–133 (1993). CASPubMed Google Scholar
Kahlem, P. et al. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. Genome Res.14, 1258–1267 (2004). CASPubMedPubMed Central Google Scholar
Reeves, R. H. et al. A mouse model for Down syndrome exhibits learning and behavioural deficits. Nature Genet.11, 177–184 (1995). First phenotypic analysis of the most-used mouse model with partial trisomy 16. CASPubMed Google Scholar
Baxter, L. L., Moran, T. H., Richtsmeier, J. T., Troncoso, J. & Reeves, R. H. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum. Mol. Genet.9, 195–202 (2000). CASPubMed Google Scholar
Costa, A. C., Walsh, K. & Davisson, M. T. Motor dysfunction in a mouse model for Down syndrome. Physiol. Behav.68, 211–220 (1999). CASPubMed Google Scholar
Escorihuela, R. M. et al. Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome. Neurosci. Lett.247, 171–174 (1998). CASPubMed Google Scholar
Dierssen, M. et al. Murine models for Down syndrome. Physiol. Behav.73, 859–871 (2001). CASPubMed Google Scholar
Richtsmeier, J. T., Baxter, L. L. & Reeves, R. H. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice. Dev. Dyn.217, 137–145 (2000). CASPubMed Google Scholar
Delcroix, J. D. et al. Trafficking the NGF signal: implications for normal and degenerating neurons. Prog. Brain Res.146, 3–23 (2004). CASPubMed Google Scholar
Cooper, J. D. et al. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc. Natl Acad. Sci. USA98, 10439–10444 (2001). CASPubMedPubMed Central Google Scholar
Sago, H. et al. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc. Natl Acad. Sci. USA95, 6256–6261 (1998). CASPubMedPubMed Central Google Scholar
Sago, H. et al. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr. Res.48, 606–613 (2000). CASPubMed Google Scholar
Shinohara, T. et al. Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome. Hum. Mol. Genet.10, 1163–1175 (2001). CASPubMed Google Scholar
Maroun, L. E., Heffernan, T. N. & Hallam, D. M. Partial IFN-α/β and IFN-γ receptor knockout trisomy 16 mouse fetuses show improved growth and cultured neuron viability. J. Interferon Cytokine Res.20, 197–203 ( 2000). CASPubMed Google Scholar
Epstein, C. J. et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc. Natl Acad. Sci. USA84, 8044–8048 (1987). First description of single-gene transgenic mouse model to study the overexpression consequences of a HSA21 gene. CASPubMedPubMed Central Google Scholar
Chrast, R. et al. Mice trisomic for a bacterial artificial chromosome with the single-minded 2 gene (Sim2) show phenotypes similar to some of those present in the partial trisomy 16 mouse models of Down syndrome. Hum. Mol. Genet.9, 1853–1864 (2000). CASPubMed Google Scholar
Sumarsono, S. H. et al. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice. Nature379, 534–537 (1996). CASPubMed Google Scholar
Lejeune, J., Gautier, M. & Turpin, R. Études des chromosomes somatiques de neuf enfants mongoliens. C. R. Acad. Sci.248, 1721–1722 (1959). A classic paper. The first description of trisomy 21. CAS Google Scholar
Lyle, R., Gehrig, C., Neergaard-Henrichsen, C., Deutsch, S. & Antonarakis, S. E. Gene expression from the aneuploid chromosome in a trisomy mouse model of Down syndrome. Genome Res.14, 1268–1274 (2004). CASPubMedPubMed Central Google Scholar
Reymond, A. et al. Human chromosome 21 gene expression atlas in the mouse. Nature420, 582–586 (2002). HSA21 gene expression atlas in the mouse. CASPubMed Google Scholar
Gitton, Y. et al. A gene expression map of human chromosome 21 orthologues in the mouse. Nature420, 586–590 (2002). A gene expression map of HSA21 orthologues in the mouse. CASPubMed Google Scholar
FitzPatrick, D. R. et al. Transcriptome analysis of human autosomal trisomy. Hum. Mol. Genet.11, 3249–3256 (2002). CASPubMed Google Scholar
Mao, R., Zielke, C. L., Zielke, H. R. & Pevsner, J. Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics81, 457–467 (2003). CASPubMed Google Scholar
Saran, N. G., Pletcher, M. T., Natale, J. E., Cheng, Y. & Reeves, R. H. Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Hum. Mol. Genet.12, 2013–2019 (2003). CASPubMed Google Scholar
Chrast, R. et al. The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals. Genome Res.10, 2006–2021 (2000). CASPubMedPubMed Central Google Scholar
Barlow, G. M. et al. Down syndrome congenital heart disease: a narrowed region and a candidate gene. Genet. Med.3, 91–101 (2001). CASPubMed Google Scholar
Korenberg, J. R. et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc. Natl Acad. Sci. USA91, 4997–5001 (1994). CASPubMedPubMed Central Google Scholar
Delabar, J. M. et al. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur. J. Hum. Genet.1, 114–124 (1993). Systematic attempt to define chromosomal trisomic regions resulting in Down syndrome phenotypes. CASPubMed Google Scholar
Kuo, W. L. et al. Detection of aneuploidy involving chromosomes 13, 18, or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes. Am. J. Hum. Genet.49, 112–119 (1991). CASPubMedPubMed Central Google Scholar
Armour, J. A., Sismani, C., Patsalis, P. C. & Cross, G. Measurement of locus copy number by hybridisation with amplifiable probes. Nucleic Acids Res.28, 605–609 (2000). CASPubMedPubMed Central Google Scholar
Slater, H. R. et al. Rapid, high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA). J. Med. Genet.40, 907–912 (2003). CASPubMedPubMed Central Google Scholar
Deutsch, S., Choudhury, U. & Antonarakis, S. E. Detection of trisomy 21 and other aneuploidies by paralogous gene quantification. J. Med. Genet. (in the press).
Ishkanian, A. S. et al. A tiling resolution DNA microarray with complete coverage of the human genome. Nature Genet.36, 299–303 (2004). CASPubMed Google Scholar
Epstein, C. J., Epstein, L. B., Weil, J. & Cox, D. R. Trisomy 21: mechanisms and models. Ann. NY Acad. Sci.396, 107–118 (1982). CASPubMed Google Scholar
Epstein, C. J. Mechanisms of the effects of aneuploidy in mammals. Annu. Rev. Genet.22, 51–75 (1988). CASPubMed Google Scholar
Epstein, C. J. Consequences of Chromosome Imbalance: Principles, Mechanisms, and Models, (Cambridge Univ. Press, New York, 1986). Google Scholar
Meeks-Wagner, D. & Hartwell, L. H. Normal stoichiometry of histone dimer sets is necessary for high fidelity of mitotic chromosome transmission. Cell44, 43–52 (1986). CASPubMed Google Scholar
Zwart, R. & Vijverberg, H. P. Four pharmacologically distinct subtypes of α4β2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Mol. Pharmacol.54, 1124–1131 (1998). CASPubMed Google Scholar
Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y. & Lindstrom, J. Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors. Mol. Pharmacol.63, 332–341 (2003). CASPubMed Google Scholar
Antoch, M. P. et al. Functional identification of the mouse circadian Clock gene by transgenic BAC rescue. Cell89, 655–667 (1997). CASPubMedPubMed Central Google Scholar
Alkema, M. J., van der Lugt, N. M., Bobeldijk, R. C., Berns, A. & van Lohuizen, M. Transformation of axial skeleton due to overexpression of bmi-1 in transgenic mice. Nature374, 724–727 (1995). CASPubMed Google Scholar
Heitzler, P. & Simpson, P. The choice of cell fate in the epidermis of Drosophila. Cell64, 1083–1092 (1991). CASPubMed Google Scholar
Semenza, G. L., Koury, S. T., Nejfelt, M. K., Gearhart, J. D. & Antonarakis, S. E. Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc. Natl Acad. Sci. USA88, 8725–8729 (1991). CASPubMedPubMed Central Google Scholar
Singaraja, R. R. et al. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J. Biol. Chem.276, 33969–33979 (2001). CASPubMed Google Scholar
Hoffman, S. & Edelman, G. M. Kinetics of homophilic binding by embryonic and adult forms of the neural cell adhesion molecule. Proc. Natl Acad. Sci. USA80, 5762–5766 (1983). CASPubMedPubMed Central Google Scholar
Struhl, G., Struhl, K. & Macdonald, P. M. The gradient morphogen bicoid is a concentration-dependent transcriptional activator. Cell57, 1259–1273 (1989). CASPubMed Google Scholar
MacKay, V. L. et al. Gene expression analyzed by high-resolution state array analysis and quantitative proteomics: response of yeast to mating pheromone. Mol. Cell. Proteomics3, 478–489 (2004). CASPubMed Google Scholar
Baptista, M. J. et al. Heterotrisomy, a significant contributing factor to ventricular septal defect associated with Down syndrome? Hum. Genet.107, 476–482 (2000). CASPubMed Google Scholar
Ward, O. C., John Langdon Down (Royal Society of Medicine, London, 1998). Google Scholar
Wang, S. Y. et al. A high-resolution physical map of human chromosome 21p using yeast artificial chromosomes. Genome Res.9, 1059–1073 (1999). CASPubMedPubMed Central Google Scholar
Kong, A. et al. A high-resolution recombination map of the human genome. Nature Genet.31, 241–247 ( 2002). CASPubMed Google Scholar
Lynn, A. et al. Patterns of meiotic recombination on the long arm of human chromosome 21. Genome Res.10, 1319–1332 (2000). CASPubMed Google Scholar
Harrison, P. M. et al. Molecular fossils in the human genome: identification and analysis of the pseudogenes in chromosomes 21 and 22. Genome Res.12, 272–280 (2002). CASPubMedPubMed Central Google Scholar
Worton, R. G. et al. Human ribosomal RNA genes: orientation of the tandem array and conservation of the 5′ end. Science239, 64–68 (1988). CASPubMed Google Scholar
Yamada, Y. et al. A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q. Genome Res.14, 247–266 (2004). CASPubMedPubMed Central Google Scholar
Antonarakis, S. E., Lyle, R., Deutsch, S. & Reymond, A. Chromosome 21: a small land of fascinating disorders with unknown pathophysiology. Int. J. Dev. Biol.46, 89–96 (2002). CASPubMed Google Scholar
Olson, L. et al. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes. Dev. Dyn.230, 581–589 (2004). CASPubMed Google Scholar